Media reporting of ProtecT: a disconnect in information dissemination?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28462943)

Published in Prostate Cancer Prostatic Dis on May 02, 2017

Authors

M E Westerman1, B Bhindi1, R Choo2, M T Gettman1, R J Karnes1, L Klotz3, S A Boorjian1

Author Affiliations

1: Department of Urology, Mayo Clinic, Rochester, MN, USA.
2: Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
3: Department of Urology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Articles cited by this

Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med (2012) 24.06

No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80

Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06

Coverage by the news media of the benefits and risks of medications. N Engl J Med (2000) 7.50

Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med (1991) 6.51

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med (2016) 5.71

Mass media interventions: effects on health services utilisation. Cochrane Database Syst Rev (2002) 4.75

What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ (2002) 4.05

Press releases: translating research into news. JAMA (2002) 3.41

Medical scientists and health news reporting: a case of miscommunication. Ann Intern Med (1997) 2.54

How do US journalists cover treatments, tests, products, and procedures? An evaluation of 500 stories. PLoS Med (2008) 1.82

"The news is [not] all good": misrepresentations and inaccuracies in Australian news media reports on prostate cancer screening. Med J Aust (2007) 1.81

Journalists and their sources of ideas and information on medicines. Soc Sci Med (1994) 1.62

Reporting medical information: effects of press releases and newsworthiness on medical journal articles' visibility in the news media. Prev Med (2002) 1.59

Use of social media in urology: data from the American Urological Association (AUA). BJU Int (2014) 1.43

Influence of medical journal press releases on the quality of associated newspaper coverage: retrospective cohort study. BMJ (2012) 1.41

Effect of media coverage and physician advice on utilization of breast cancer screening by women 40 years and older. J Health Commun (2000) 1.35

Effect of news coverage on the prevalence of drunk-driving behavior: evidence from a longitudinal study. J Stud Alcohol (2002) 1.16

Preferences for different sources of information about cancer. Patient Educ Couns (1999) 0.98

PSA testing: press coverage in UK and US is an ocean apart. BMJ (2009) 0.91

An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer. BJU Int (2011) 0.88

'A matter of faith, not science': analysis of media coverage of prostate cancer screening in Australian news media 2003-2006. J R Soc Med (2007) 0.88

[Exponential use of social media in medicine: example of the interest of Twitter(©) in urology]. Prog Urol (2014) 0.83

Treatment or Monitoring for Early Prostate Cancer. N Engl J Med (2016) 0.78

The media and prostate cancer screening. Med J Aust (2007) 0.78

Novel use of Twitter to disseminate and evaluate adherence to clinical guidelines by the European Association of Urology. BJU Int (2017) 0.77

High tech or high risk? An analysis of media reports about robotic surgery. J Robot Surg (2016) 0.77

Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update. Neurourol Urodyn (2015) 0.77

Articles by these authors

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer Prostatic Dis (2013) 1.23

Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. Eur J Surg Oncol (2013) 0.96

The association of tumor volume with mortality following radical prostatectomy. Prostate Cancer Prostatic Dis (2014) 0.84

Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer Prostatic Dis (2015) 0.80

Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy. Prostate Cancer Prostatic Dis (2014) 0.77

Robotic partial nephrectomy: a multi-institutional analysis. J Robot Surg (2008) 0.76

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene (2017) 0.75

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk. Prostate Cancer Prostatic Dis (2016) 0.75

Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer Prostatic Dis (2014) 0.75

The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer. Prostate Cancer Prostatic Dis (2017) 0.75

Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis. Prostate Cancer Prostatic Dis (2017) 0.75